|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01643 MODERN CHI MED
Nominal 
2.010 +0.080 (+4.145%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 214,068 | 344,075 | 399,656 | 360,695 |
| Cost of Sales | -- | -- | (158,871) | (239,900) | (228,870) | (202,267) |
| Gross Profit | -- | -- | 55,197 | 104,175 | 170,786 | 158,428 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | -- | -- | 14,819 | 68,306 | 124,324 | 114,222 | |
| Taxation | -- | -- | (5,149) | (19,511) | (36,495) | (32,446) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (13,557) | -- | 9,670 | 48,795 | 87,829 | 81,776 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | (765) | (901) | (661) | (347) |
| Depreciation & Amortisation | -- | -- | 9,274 | 6,440 | 5,691 | 2,723 |
| Directors' Emoluments | -- | -- | 1,524 | 1,637 | 1,666 | 1,952 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -2.050 | -- | 1.610 | 8.130 | 14.640 | 13.770 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 1.361 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 9.881% |
| Cash flow per share ($) | -- | -- | 0.098 | 0.014 | 0.210 | 0.097 |
| NBV per share ($) | -- | -- | 0.807 | 0.788 | 0.705 | 0.562 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -13,557 |
| %Change | -- |
| EPS / (LPS) | RMB -0.021 |
| NBV Per Share (¥) | RMB -- |